Cargando…

Bacterial melanin in rat models of Parkinson's disease: a potential neuroprotective strategy

Detalles Bibliográficos
Autor principal:	Petrosyan, Tigran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392666/ https://www.ncbi.nlm.nih.gov/pubmed/25883617 http://dx.doi.org/10.4103/1673-5374.152372

Ejemplares similares

Bacterial melanin crosses the blood–brain barrier in rat experimental model
por: Petrosyan, Tigran, et al.
Publicado: (2014)

Parkinson’s disease-associated melanin steal
por: Hinz, Marty, et al.
Publicado: (2014)

Bacterial melanin promotes recovery after sciatic nerve injury in rats
por: Gevorkyan, Olga. V., et al.
Publicado: (2015)

Evaluating rehabilitation interventions in Parkinson's disease with functional MRI: a promising neuroprotective strategy
por: Mallio, Carlo Augusto, et al.
Publicado: (2015)

Detection of Ca(2+)-dependent acid phosphatase activity identifies neuronal integrity in damaged rat central nervous system after application of bacterial melanin
por: Petrosyan, Tigran R., et al.
Publicado: (2016)

The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson’s disease
por: Serafino, Annalucia, et al.
Publicado: (2022)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

Why and how does light therapy offer neuroprotection in Parkinson's disease?
por: Mitrofanis, John
Publicado: (2017)

Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's disease
por: Spittau, Björn
Publicado: (2017)

Remote photobiomodulation: an emerging strategy for neuroprotection
por: Gordon, Luke C., et al.
Publicado: (2019)

Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease
por: Thornton, Emma, et al.
Publicado: (2015)

The inositol metabolism pathway as a target for neuroprotective strategies
por: Nystuen, Arne M., et al.
Publicado: (2015)

The neuroprotective potential of endoplasmic reticulum chaperones
por: McLaughlin, Todd, et al.
Publicado: (2015)

Immunomodulation as a neuroprotective strategy after spinal cord injury
por: Monteiro, Susana, et al.
Publicado: (2018)

How does zebrafish support new strategies for neuroprotection and neuroregeneration in hypoxia-related diseases?
por: Silva, Emerson S., et al.
Publicado: (2016)

Propolis as a Potential Disease-Modifying Strategy in Parkinson’s disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model
por: C. Gonçalves, Valeria, et al.
Publicado: (2020)

Inhibition of microglial activation and induction of neurotrophic factors by flavonoids: a potential therapeutic strategy against Parkinson's disease
por: Kim, Sang Ryong
Publicado: (2015)

Fractalkine: multiple strategies to counteract glutamate receptors activation leading to neuroprotection
por: Lauro, Clotilde
Publicado: (2015)

Potential role of biofeedback therapy for Parkinson’s disease
por: Kotani, Naoya, et al.
Publicado: (2021)

Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies?
por: Qureshi, Sara S., et al.
Publicado: (2015)

Neuroprotection induced by NMDA preconditioning as a strategy to understand brain tolerance mechanism
por: Constantino, Leandra C., et al.
Publicado: (2015)

Excitotoxicity-induced endocytosis as a potential target for stroke neuroprotection
por: Díaz-Guerra, Margarita
Publicado: (2020)

Parkinson’s Disease-Associated Melanin Steal [Retraction]
Publicado: (2021)

Adenosine triphosphate maintenance by branched chain amino acids as a novel neuroprotective strategy for retinal neurodegenerative diseases
por: Hasegawa, Tomoko, et al.
Publicado: (2019)

Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism
por: McMahon, Benjamin, et al.
Publicado: (2016)

Intracellular sorting pathways of the amyloid precursor protein provide novel neuroprotective strategies
por: Hermey, Guido
Publicado: (2015)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Limited therapeutic potential of astrocyte elevated gene-1 transduction in an animal model of Parkinson's disease
por: Leem, Eunju, et al.
Publicado: (2020)

Retinal ganglion cell protection by hop-flower extract as a novel neuroprotective strategy for glaucoma
por: Hasegawa, Tomoko, et al.
Publicado: (2021)

Restoration of GABA(B) receptor expression in cerebral ischemia: a promising novel neuroprotective strategy
por: Bhat, Musadiq A., et al.
Publicado: (2023)

Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects
por: Li Volti, Giovanni, et al.
Publicado: (2016)

Sigma-1 receptor: a potential new target for Parkinson's disease?
por: Francardo, Veronica
Publicado: (2014)

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
Publicado: (2020)

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
por: Kramer, Edgar R.
Publicado: (2015)

Spinal cord injury: potential neuroprotective therapy based on neural-derived peptides
por: García, Elisa, et al.
Publicado: (2016)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Neuroprotective properties of kavalactones
por: Tzeng, Yew-Min, et al.
Publicado: (2015)

Food, polyphenols and neuroprotection
por: Silva, Rui F.M., et al.
Publicado: (2017)

The dual role of necrostatin-1 in Parkinson’s disease models
por: Alegre-Cortés, Eva, et al.
Publicado: (2021)

Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectives
por: Kalani, Anuradha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qtjuj5hvpflrqg8obhe2mmebkt